Skip to content

Taking Measure of Countermeasures (Part 1): A Review of Government and Industry Efforts to Protect the Homeland through Accelerated Research, Development, and Acquisition of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures

Date: Wednesday, April 13, 2011 Time: 02:00 PM Location: 311 Cannon House Office Building, Washington, DC 20515 Subcommittee: Emergency Preparedness, Response, & Communications (112th Congress) Issue: Health

Witnesses

Witnesses

  • Ms. Cynthia Bascetta, Managing Director, Health Care, Government Accountability Office
  • Dr. Segaran P. Pillai, Chief Medical and Science Advisor, Chemical and Biological Division, Science and Technology Directorate, Department of Homeland Security
  • Dr. Richard J. Hatchett, Chief Medical Officer and Deputy Director, Strategic Sciences and Management, Department of Health and Human Services
  • Dr. Gerald W. Parker, Deputy Assistant to the Secretary of Defense, Chemical and Biological Defense, Department of Defense
  • Ms. Phyllis Arthur, Senior Director, Vaccines, Immunotherapeutics, and Diagnostics Policy, Biotechnology Industry Organization
  • Mr. John M. Clerici, Principal, Tiber Creek Partners LLC
  • Dr. Daniel Fagbuyi, Medical Director, Disaster Preparedness and Emergency Management, Children's National Medical Center

Documents

# # #
Media contact: Adam Comis at (202) 225-9978